Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

NCT02521285 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

NIH

Sponsor class

Conditions

Barrett Esophagus
Esophageal Adenocarcinoma

Interventions

DRUG: Aspirin
OTHER: Laboratory Biomarker Analysis
OTHER: Placebo Administration
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)